Endovascular therapy of lower extremity arterial occlusive disease: are advanced generation devices worth the cost?
- PMID: 8158081
Endovascular therapy of lower extremity arterial occlusive disease: are advanced generation devices worth the cost?
Abstract
Endovascular recanalization has a relatively small but important role in the treatment of arterial occlusive disease. The balloon angioplasty catheter remains the most versatile and successful tool for transluminal therapy. A multitude of advanced generation devices have been developed in recent years; of these, intravascular stents are gradually emerging as most useful and capable of enhancing the results of angioplasty in selected instances.
Similar articles
-
Endovascular interventions in iliac and infrainguinal occlusive artery disease.J Interv Cardiol. 2004 Dec;17(6):427-35. doi: 10.1111/j.1540-8183.2004.04086.x. J Interv Cardiol. 2004. PMID: 15546296 Review.
-
[Endovascular therapy options in femoro-popliteal PAD].Rofo. 2010 Sep;182(9):755-63. doi: 10.1055/s-0029-1245501. Epub 2010 Jul 5. Rofo. 2010. PMID: 20603777 Review. German.
-
Endovascular treatment of femoro-popliteal obstructive disease.Minerva Cardioangiol. 2007 Feb;55(1):125-32. Minerva Cardioangiol. 2007. PMID: 17287687 Review.
-
The role of endovascular therapy in lower extremity revascularization. Lessons learned and current strategies.Int Angiol. 1993 Sep;12(3):221-30. Int Angiol. 1993. PMID: 8151164 Review.
-
[Endovascular treatment of arterial occlusive disease of the iliac arteries].Rev Invest Clin. 2001 Nov-Dec;53(6):543-51. Rev Invest Clin. 2001. PMID: 11921528 Review. Spanish.